NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/21/2024
Back to search
Official data from USPTO
PHARMALIFE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
08/21/2024
Trademark type
Combined
Nice classes
5
Filing date
04/23/2013
Registration date
06/02/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/21/2024
Last transaction
08/21/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
03/28/1999
First use in commerce
03/28/1999
Drawing code
3
Owner type
01
Owner location
Syosset, NY, US
Examiner
PHILLIPS, WENDELL
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "PHARMALIFE" with the top of the "L" branching apart with three circular, shaded, bubble-like objects above the "L".
Holders and representatives
Holders
Sayage, Larry
Representatives
Leo G. Lenna SORELL, LENNA & SCHMIDT, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
nutritional supplements
Publications
History of USPTO decisions and trademark events.
43 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/21/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/21/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/21/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
06/06/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/02/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/02/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/02/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/02/2021
E815
TEAS SECTION 8 & 15 RECEIVED
05/14/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2015
PUBO
PUBLISHED FOR OPPOSITION
03/17/2015
NPUB
NOTICE OF PUBLICATION
02/25/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/07/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/28/2015
CNSL
LETTER OF SUSPENSION MAILED
12/23/2014
CNSL
SUSPENSION LETTER WRITTEN
12/22/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2014
NREV
NOTICE OF REVIVAL - MAILED
12/10/2014
PGRR
PETITION GRANTED - RESPONSE RECEIVED
12/10/2014
PINM
INCOMPLETE PETITION NOTICE MAILED
12/05/2014
APET
ASSIGNED TO PETITION STAFF
12/04/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/14/2014
PROA
TEAS PETITION TO REVIVE RECEIVED
11/14/2014
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
10/17/2014
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
10/16/2014
CNFR
FINAL REFUSAL MAILED
03/10/2014
CNFR
FINAL REFUSAL WRITTEN
03/07/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/15/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2014
CNRT
NON-FINAL ACTION MAILED
08/13/2013
CNRT
NON-FINAL ACTION WRITTEN
08/13/2013
DMCC
DATA MODIFICATION COMPLETED
08/13/2013
ALIE
ASSIGNED TO LIE
08/12/2013
DOCK
ASSIGNED TO EXAMINER
08/09/2013
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
05/01/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/30/2013
NWAP
NEW APPLICATION ENTERED
04/26/2013
Continuous trademark protection
Get notified about every new filing that threatens PHARMALIFE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.